The operation launched 1,728 investigations in 91 countries and shut down 13,000 criminal-linked websites, social media pages, channels, and bots used to market and sell illegal or counterfeit medicines.
Read MoreOn June 26, PSM commented in support proposed revisions to forms FDA 3500 and FDA 3500B, which are used to report adverse events from prescription and over-the-counter medicines.
Read MoreMore than 40 cases of botulism linked to Botox injections have been reported in the U.S. and U.K. over the last two months.
Read MoreThe bill permanently schedules fentanyl analogues as Schedule I drugs under the Controlled Substances Act.
Read MoreThe Jha brothers admitted selling counterfeit Keytruda and other prescription drugs to undercover agents.
Read MorePSM is soliciting feedback on draft best practices until June 20th. Please review the guidelines and send your thoughts to editors@safemedicines.org.
Read MoreThe FDA warned companies over the sale of an unapproved medical device and contaminated eye medicines, and disbarred a Texan who sold illegally imported pharmaceuticals.
Read MoreThe FDA has announced a voluntary nationwide recall of two dietary supplements sold exclusively online by www.umary-usa.com. Lab testing revealed that Unavy Ácido HIALURÓNICO and Umovy Ácido HIALURÓNICO contain undeclared active pharmaceutical ingredients: diclofenac, dexamethasone, and omeprazole.
Read MoreFederally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.
Read MoreOperation RapTor led to 270 arrests and the seizure of more than $200 million in currency and digital assets.
Read More